Herbert Smith Freehills (London)

Max Kaufman

Herbert Smith Freehills (London)
Senior Associate

Max Kaufman is a senior associate at Herbert Smith Freehills. He specialises in EU and UK competition law, with particular experience in EU and national merger control filings and antitrust investigations and advice (anti-competitive agreements and abuses of dominance). He also has significant experience advising on UK regulatory law and EU and UK sports law. Max has been involved in cases before the UK competition authorities and the European Commission and has particular experience of the energy, financial services, infrastructure, pharmaceutical, telecoms and sports sectors. He also has significant experience in UK regulatory law, particularly in the electricity and gas sector. In the sports sector, Max has provided extensive advice on EU and UK sports law and, particularly, its interaction with competition law and has assisted clients with the regulatory requirements and risks around the acquisition of UK sports clubs.

Linked authors

Herbert Smith Freehills (Melbourne)
Herbert Smith Freehills (London)
Herbert Smith Freehills (Johannesburg)
Herbert Smith Freehills (London)
Herbert Smith Freehills (London)


604 Bulletin

Kyriakos Fountoukakos, Natalia Rodriguez, Max Kaufman, Peter Rowland The UK Competition Authority issues guidance to permit pharmaceutical companies to work together on Combination Therapies


On 17 November 2023, the CMA issued a Prioritisation Statement (the Statement) indicating that it would not prioritise investigations under Chapter I of the Competition Act 1998 (the CA 98) of exchanges of competitively sensitive information (CSI) and/or agreements between medicine (...)

Kyriakos Fountoukakos, Max Kaufman, Kristien Geeurickx, Agathe Célarié The EU Commission accepts the commitment offered by a pharmaceutical company to reduce drug prices by 73% (Aspen)


“When the price of a drug suddenly goes up by several hundred percent, this is something the Commission may look at” Commissioner Vestager said when opening a formal investigation into Aspen’s alleged excessive pricing conduct in May 2017. On 10 February 2021, the EU Commission (Commission) (...)


Total visits

Number of readings per contribution

Number of contributions

Author's ranking
In number of contributions
In number of visits
In average number of visits
Send a message